AYR Carrick and Cumnock MP Allan Dorans is backing Alzheimer’s Research UK’s call for a new Dementia Medicines Taskforce to radically speed up the development and roll-out of new treatments for people with dementia.

It is estimated that around 1,467 people have dementia in the constituency. By 2030, dementia will be the most expensive health condition of the UK’s top causes of death, costing £30 billion a year.

A Dementia Medicines Taskforce would bring together representatives from industry, the NHS, charities and researchers, with a single focus on

fast-tracking the development and delivery of

new medicines for diseases like Alzheimer’s.

With a bold and co-ordinated approach, the Taskforce would build on vital research and scientific breakthroughs to improve diagnosis as well as enhance late-stage clinical trials in the UK and enable regulators to rapidly assess new medicines.

Mr Dorans said: “I fully support Alzheimer’s Research UK’s inspiring idea for a Dementia Medicines Taskforce. It’s vital we continue to build on the progress made in dementia research and ensure that people with dementia receive new treatments as soon as they become available.

“A Dementia Medicines Taskforce would capitalise on our world-leading life sciences sector, and help make a huge difference to the lives of people affected by dementia.

“I have written to Lord Kamall urging him to ensure this policy is a key part of the government’s forthcoming 10-year dementia strategy.”

David Thomas, Head of Policy, at Alzheimer’s Research UK, said: “We’re delighted to have the support of Allan Dorans on such an important issue.

“People with dementia need MPs like Allan who will champion research.”